Zebin Lin
Impact in
-
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in ⓘ
-
- Gut microbiota and health 6
- Metabolomics and Mass Spectrometry Studies 3
-
- Clostridium difficile and Clostridium perfringens research 2
- Co-authors
- Ke‐Xuan Liu (12 shared papers)Qi‐Shun Sun (12 shared papers)Jingjuan Hu (11 shared papers)Fan Deng (10 shared papers)Bing-Cheng Zhao (5 shared papers)Xiao Yang (3 shared papers)Zhengzheng Yan (3 shared papers)Li Cai (1 shared paper)
- Journals
- Nature Communications (2 papers)International Journal of Biological Sciences (2 papers)Gut Microbes (2 papers)Rapid Prototyping Journal (1 paper)Cell Reports Medicine (1 paper)
- Partner nations
- ChinaMexicoUnited States
In The Last Decade
Zebin Lin
17 papers receiving 670 citations
Hit Papers
Peers
Comparison fields: 5 of 95
- Biological Psychiatry 30
- Cancer Research 101
- Critical Care and Intensive Care Medicine 34
- Molecular Biology 395
- Gastroenterology 22
Countries citing papers authored by Zebin Lin
This map shows the geographic impact of Zebin Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zebin Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zebin Lin more than expected).
Fields of papers citing papers by Zebin Lin
This network shows the impact of papers produced by Zebin Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zebin Lin. The network helps show where Zebin Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Zebin Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | The gut microbiota metabolite capsiate promotes Gpx4 expression by activating TRPV1 to inhibit intestinal ischemia reperfusion-induced ferroptosis Hit paper breakdown → | 2021 | 186 |
| 2 | Lactobacillus murinus alleviate intestinal ischemia/reperfusion injury through promoting the release of interleukin-10 from M2 macrophages via Toll-like receptor 2 signaling Hit paper breakdown → | 2022 | 166 |
| 3 | 2022 | 44 | |
| 4 | 2022 | 39 | |
| 5 | 2023 | 36 | |
| 6 | 2023 | 32 | |
| 7 | 2021 | 31 | |
| 8 | 2017 | 28 | |
| 9 | 2018 | 24 | |
| 10 | 2020 | 19 | |
| 11 | 2023 | 19 | |
| 12 | 2022 | 15 | |
| 13 | 2012 | 15 | |
| 14 | 2013 | 14 | |
| 15 | 2020 | 7 | |
| 16 | 2025 | 1 | |
| 17 | 2022 | 1 | |
| 18 | 2025 | 0 | |
| 19 | 2025 | 0 |
About Zebin Lin
Zebin Lin is a scholar working on Molecular Biology, Infectious Diseases, Critical Care and Intensive Care Medicine, Immunology and Cancer Research, having authored 19 papers that have together received 677 indexed citations. Recurring topics across this work include Gut microbiota and health (6 papers), Metabolomics and Mass Spectrometry Studies (3 papers), MicroRNA in disease regulation (2 papers), Mesenchymal stem cell research (2 papers), Additive Manufacturing Materials and Processes (2 papers), Intensive Care Unit Cognitive Disorders (2 papers), Clostridium difficile and Clostridium perfringens research (2 papers) and Cardiac Ischemia and Reperfusion (2 papers). The work is most often cited by research in Biological Psychiatry (30 citations), Cancer Research (101 citations), Critical Care and Intensive Care Medicine (34 citations), Molecular Biology (395 citations) and Gastroenterology (22 citations). Zebin Lin has collaborated with scholars based in China, Mexico and United States. Frequent co-authors include Ke‐Xuan Liu, Qi‐Shun Sun, Jingjuan Hu, Fan Deng, Bing-Cheng Zhao, Xiao Yang, Zhengzheng Yan, Li Cai, Weifeng Liu and Yifan Wang. Their work appears in journals such as Nature Communications, International Journal of Biological Sciences, Gut Microbes, Rapid Prototyping Journal and Cell Reports Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.